...2008-09-19 Company Name: Eli Lilly Contact: Recruiter Phone: email only ... Experience 3 Functional Area Sales - Lilly Expertise Sales-Pharmaceutical Job Type ... clinical and reimbursement information about Lilly Oncologys products and services for ... provide assistance for offices, establish Lilly Oncology reputation in key academic ... MotherBest Companies for Working MothersT LILLY IS AN EQUAL OPPORTUNITY EMPLOYER ...

...-09-19 Company Name: Eli Lilly Contact: Recruiter Phone: email only ... Not Indicated Functional Area Sales - Lilly Expertise Sales-Pharmaceutical Job Type ...flawless collaboration and communication between Lilly/DSI counterparts (office based and...scenarios (hospital) to sustain consistent Lilly service and maximize full continuum...of care. * Professionally promote multiple Lilly products to healthcare professionals * Provide...

..., for instance, Dr. Biederman received a grant from the National Institutes of Health to study in children Strattera, an Eli Lilly drug for attention deficit disorder. Dr. Biederman reported to Harvard that he received less than $10,000 from Lilly that year, but the company told Mr. Grassley that it paid Dr. Biederman more than $14,000 in 2000, Mr....

... 2000, for instance, Dr. Biederman received a grant from the National Institutes of Health to study in children Strattera, an Eli Lilly drug for attention deficit disorder. Dr. Biederman reported to Harvard that he received less than $10,000 from Lilly that year, but the company told Mr. Grassley that it paid Dr. Biederman more than $14,000 in 2000, Mr....

...8.html Apri1 14, 2008 Eli Lilly Markets Its Dangerous New Drug as...the suicide. After Johnson's death, Lilly was ordered to stop accepting new...took their lives according to a Lilly clinical psychiatrist, Dr. John R. ...Web site in June, 2005, leading Lilly to precipitously withdraw its application to.... But last fall it ordered Lilly to stop downplaying liver toxicity ... Cymbalta might start sooner than Lilly expects--in a wrongful death ...

... research to find a "cure," the research already being done at the NIH will be simply expanded and intensified. What have they done to help us so far? I'm aware of nothing useful. And on top of that, when Lilly came up with a safer derivative of Prozac (difluoxetine) they failed to market it. Presumably they wouldn't want to market one that causes less suicide according to the patent application. Maybe that one is for their employees. Who ...

... they were getting from drugmakers. While the Harvard faculty members were doing their research, some of it paid for by taxpayers, they were quietly taking millions of dollars from drug companies such as Johnson & Johnson, Eli Lilly and others that profited from the findings, the New York Times reported. The researchers were supposed to report earnings in excess of $10,000 as consultants for drug companies, but they failed to do so. Even...

...In 2000, for instance, Dr. Biederman received a grant from the National Institutes of Health to study in children Strattera, an Eli Lilly drug for attention deficit disorder. Dr. Biederman reported to Harvard that he received less than $10,000 from Lilly that year, but the company told Mr. Grassley that it paid Dr. Biederman more than $14,000 in 2000, Mr. ...

... of the newer class of so-called atypical antipsychotic drugs... Atypical antipsychotic drugs, which the study said had been available for about a decade, include risperidone, marketed by Johnson & Johnson as Risperdal; olanzapine, made by Eli Lilly and Co under the brand name Zyprexa; and quetiapine, sold by AstraZeneca Plc under the brand name Seroquel. Complete article here: http://www.guardian.co.uk/business/feedarticle/7541460

... about the lawsuit. 10 States have sued Eli Lilly regarding Zyprexa: Alaska, Connecticut, Louisiana, Mississippi, Montana, ...Johnson &Johnson Inc., in November 2006 and Eli Lilly & Co. of Indianapolis on May 1. McDaniel’s ...patients who suffered ill effects after taking them. Eli Lilly settled its case with Alaska in the midst of... filing suit, certainly no resolution was reached.” Eli Lilly has until early June to respond to Arkansas’ ...